 WALTHAM, Mass., Sept. 27, 2021 GLOBE NEWSWIRE -- Dyne Therapeutics, Inc. Nasdaq: DYN, a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to present during Chardans Virtual 5th Annual Genetic Medicines Conference. 